HIPPOlino - interdisciplinary skin cancer prevention training for immunocompressed children and adolescents

Not Applicable

Conditions: Skin cancer (ICD-10 C43/C44)Skin infections (ICD-10 L00-L08)

Registration Number: DRKS00011393

Lead Sponsor: Deutsche Krebshilfe e.V.

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 127

Inclusion Criteria

Organ transplanted children and adolescents aged between 5 and 22 years
Type I-III to Fitzpatrick
Immunosuppression at the time of inclusion in the study, including complete information on the type, amount and duration of immunosuppression
Written consent of the young people and their parents to participate in the study
Daily access possibilities of the young people or the parents on a mobile phone for sending SMS
Transfer of the telephone number and the place of residence to the German Weather Service
Known living-place in the intervention period for sending SMS
Signed release from medical confidentiality

Exclusion Criteria

Organ transplant recipients > 22 years
No longer required immunosuppression during the study period (e.g., transplant failure)
Multi-week stay abroad during the intervening period of access to a mobile phone
Skin types IV-VI of Fitzpatrick (extremely low baseline skin cancer risk)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase in knowledge (for example, the question concerning the UV index)<br>Behavioral change (e.g., questions about avoiding sunglasses, improving sun protection)<br><br>These parameters are evaluated with the help of questionnaires, which are completed by the participants before the training as well as 1, 6 and 12 months later.

Secondary Outcome Measures

Name	Time	Method
Count of nevi (as a surrogate parameter) at the times T0 and T3. Change in the number of nevii among the groups and in relation to data in the questionnaire (e.g. UV-light sensitivity)<br>Evaluation of doctor's letters (information on skin tumors and infections, immunosuppression)